Company Search:
Advanced Search
Sponsored Links
Achaogen Inc Company Snapshot
Achaogen Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Achaogen Inc with three other companies in this sector in UNITED STATES : Inhibrx Inc (2018 sales of $8.60 million of which 100% was Biologic therapeutic candidates), AbCellera Biologics Inc ($8.83 million of which 100% was Discovery & development of antibodies), and Kalvista Pharmaceuticals Inc ($8.39 million ).

Sales Analysis. Achaogen Inc reported sales of $8.73 million for the year ending December of 2018. This represents a decrease of 21.9% versus 2017, when the company's sales were $11.18 million.
  Stock Performance Chart for Achaogen Inc
  Stock Data: Recent Stock Performance:
  Current Price (5/7/2021): .02
(Figures in U.S. Dollars)
1 Week -23.0%   13 Weeks -15.1%  
4 Weeks 118.9%   52 Weeks 60.0%  
Achaogen Inc Key Data:
  Ticker: AKAOQ Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 8,728,000
(Year Ending Jan 2019).
Employees: 42
  Currency: U.S. Dollars Market Cap: 1,328,704
  Fiscal Yr Ends: December Shares Outstanding: 63,879,995
  Share Type: Common Closely Held Shares: 7,413,383
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.